Meta Unwinds $2B Manus Deal as Insiders Sell

NEW YORK, June 16 —

Meta Platforms is reportedly unwinding a $2 billion deal with Manus, per a Barchart.com report published June 16, just as four members of its senior leadership team collectively sold $15.97 million in shares over 90 days with zero purchases to offset them. A deal collapsing is news. A deal collapsing while the COO, CTO, CFO, and CLO are all simultaneously cashing out is a pattern that deserves more than a passing glance.

What Fell Apart

No public source has disclosed the specific terms or rationale behind the Manus dissolution. Walking back a $2 billion commitment suggests more than minor operational reasons. Whether Meta's in-house AI development overtook the strategic logic for the deal or the Manus technology failed to integrate at scale, the "why" is exactly what investors need and don't have. With management silent, the market writes its own story.

Every Seat at the Table Was Selling

COO Javier Olivan executed open-market sales on May 18, May 26, and June 1 at prices ranging from approximately $608.98 to $629.29 per share. CTO Andrew Bosworth sold approximately 7,847 shares across eight tranches on May 18 alone, at prices between $604.51 and $611.83, totaling approximately $4.77 million. CFO Susan Li sold across multiple tranches on May 15 and May 18 at prices ranging from approximately $604.63 to $618.43. Chief Legal Officer Curtis Mahoney sold 2,079 shares at $609.92 on May 27 for approximately $1.27 million.

Each transaction in isolation is consistent with routine planned selling: diversification, tax obligations, pre-scheduled 10b5-1 programs. The collective picture is harder to wave away. Four senior executives across operations, technology, finance, and legal all selling in a compressed window, with not a single insider purchase to offset any of it across the entire 90-day period. Insiders are under no obligation to buy. But when every seat at the table is selling and nobody is adding, that absence carries a signal even if it doesn't resolve into a directional verdict.

The Numbers That Don't Match the Selling

The tension is that the underlying business looks nothing like one people should be fleeing. Meta's trailing twelve-month revenue of $214.96 billion grew 33.1% year-over-year at an 81.9% gross margin. The most recently reported quarter came in at $8.88 EPS against analyst estimates of approximately $8.18, per the April 29 8-K filing. The two preceding quarters also beat: $7.25 versus $6.67 estimated, and $7.14 versus $5.86 estimated. Three consecutive beats at accelerating EPS levels is not an accident.

At 16.7x forward earnings, the stock is not priced for a company growing revenue at 33%. Shares trade at $603.86 against an analyst consensus price target of $827.32, a gap of approximately $223 per share. That gap is either a genuine opportunity or a signal that the consensus is running ahead of reality. The Manus unwind and the insider selling together raise the probability that at least some of the caution is earned. See the full DCF model and price target →

What Changes the Read

The most important near-term catalyst is whether Meta addresses the Manus unwind directly. An investor day comment or an 8-K clarification could reframe the deal's collapse as disciplined capital reallocation rather than a strategic stumble. The former would be constructive for the stock; the latter would invite harder questions about the $2 billion in capital deployed and what it produced.

On the insider side, the next 90-day window runs through mid-September. A pattern of open-market purchases in that period would significantly shift the interpretation. Continued one-way selling would not. The long-horizon bull case rests on execution that three quarters of earnings data support. The near-term case for adding to positions requires a little more patience than the fundamentals alone suggest.

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

What was Meta's $2 billion deal with Manus?

Meta Platforms reportedly committed $2 billion to a deal with Manus, an AI agent company. Per a Barchart.com report published June 16, 2026, Meta is now unwinding that deal. Meta has not publicly disclosed the specific reasons for the dissolution.

Why are Meta insiders selling shares?

COO Javier Olivan, CTO Andrew Bosworth, CFO Susan Li, and CLO Curtis Mahoney all executed open-market stock sales between mid-May and early June 2026, totaling $15.97 million in net sales with zero insider purchases over the 90-day period. Routine diversification and pre-scheduled selling plans are common explanations for individual transactions. The absence of any counterbalancing purchases across all four executives in the same window warrants closer attention.

Is Meta stock undervalued at current prices?

Meta shares traded at $603.86 as of June 16, 2026, against an analyst consensus price target of $827.32, a gap of approximately $223 per share. The stock carries a 16.7x forward P/E, which looks modest relative to 33.1% year-over-year revenue growth. Whether that gap closes depends on how the Manus deal unwind is resolved and whether the current earnings trajectory holds.

How has Meta been performing on earnings?

Meta beat analyst EPS estimates in each of its three most recently reported quarters: $8.88 versus approximately $8.18 estimated, $7.25 versus $6.67 estimated, and $7.14 versus $5.86 estimated. Trailing twelve-month revenue reached $214.96 billion with 33.1% year-over-year growth and an 81.9% gross margin, per company filings and financial data as of June 16, 2026.

Should the insider selling pattern affect how investors view META?

The pattern is worth disclosing but does not determine a clear directional view. Insider selling has many legitimate explanations and is far more common than insider buying for executives at large-cap companies. The more significant consideration is the combination of an unexpected deal unwind and coordinated selling across four senior roles simultaneously. That combination introduces near-term uncertainty even as earnings and revenue trends remain strong.